SE420921B - Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan - Google Patents
Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkanInfo
- Publication number
- SE420921B SE420921B SE7508101A SE7508101A SE420921B SE 420921 B SE420921 B SE 420921B SE 7508101 A SE7508101 A SE 7508101A SE 7508101 A SE7508101 A SE 7508101A SE 420921 B SE420921 B SE 420921B
- Authority
- SE
- Sweden
- Prior art keywords
- preparing
- therapeutical effect
- analogy procedure
- chinazoline derivatives
- chinazoline
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3280574 | 1974-07-25 | ||
| GB41675*[A GB1460389A (en) | 1974-07-25 | 1975-01-06 | 4-substituted quinazoline cardiac stimulants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7508101L SE7508101L (sv) | 1976-01-26 |
| SE420921B true SE420921B (sv) | 1981-11-09 |
Family
ID=26235904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7508101A SE420921B (sv) | 1974-07-25 | 1975-07-15 | Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4001422A (bg) |
| JP (1) | JPS5527062B2 (bg) |
| AR (7) | AR216046A1 (bg) |
| BG (2) | BG27086A3 (bg) |
| CA (1) | CA1060445A (bg) |
| CH (2) | CH611616A5 (bg) |
| DD (1) | DD119046A5 (bg) |
| DE (1) | DE2530894C2 (bg) |
| DK (1) | DK138800B (bg) |
| FI (1) | FI66182C (bg) |
| FR (1) | FR2279406A1 (bg) |
| GB (1) | GB1460389A (bg) |
| HK (1) | HK61879A (bg) |
| IE (1) | IE41838B1 (bg) |
| IL (1) | IL47625A (bg) |
| KE (1) | KE2988A (bg) |
| LU (1) | LU73072A1 (bg) |
| MY (1) | MY8000108A (bg) |
| NL (1) | NL159982C (bg) |
| PH (1) | PH14190A (bg) |
| RO (3) | RO69296A (bg) |
| SE (1) | SE420921B (bg) |
| YU (3) | YU37155B (bg) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN148482B (bg) | 1977-06-03 | 1981-03-07 | Pfizer | |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
| US4370328A (en) * | 1977-11-03 | 1983-01-25 | Pfizer Inc. | Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines |
| US4489075A (en) * | 1982-05-15 | 1984-12-18 | Pfizer Inc. | Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| FR2802206B1 (fr) * | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| TWI283665B (en) * | 2001-09-13 | 2007-07-11 | Smithkline Beecham Plc | Novel urea compound, pharmaceutical composition containing the same and its use |
| HUP0200849A2 (hu) * | 2002-03-06 | 2004-08-30 | Sanofi-Synthelabo | N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
| US7064211B2 (en) * | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
| WO2004024710A1 (en) * | 2002-09-13 | 2004-03-25 | Glaxo Group Limited | Urea compounds active as vanilloid receptor antagonists for the treatment of pain |
| TWI350168B (en) | 2004-05-07 | 2011-10-11 | Incyte Corp | Amido compounds and their use as pharmaceuticals |
| NZ551603A (en) * | 2004-06-24 | 2010-11-26 | Incyte Corp | N-substituted piperidines and their use as pharmaceuticals |
| US20060009471A1 (en) * | 2004-06-24 | 2006-01-12 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
| JP2008504279A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| JP2008504280A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | ２−メチルプロパンアミドおよびその医薬としての使用 |
| US20060019975A1 (en) * | 2004-07-23 | 2006-01-26 | Pfizer Inc | Novel piperidyl derivatives of quinazoline and isoquinoline |
| MX2007001540A (es) * | 2004-08-10 | 2007-04-23 | Incyte Corp | Compuestos amido y sus usos como farmaceuticos. |
| US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) * | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| TW200808807A (en) * | 2006-03-02 | 2008-02-16 | Incyte Corp | Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| WO2007103719A2 (en) * | 2006-03-03 | 2007-09-13 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| CA2649677A1 (en) * | 2006-05-01 | 2007-11-15 | Incyte Corporation | Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1 |
| CA2652375A1 (en) * | 2006-05-17 | 2007-11-29 | Incyte Corporation | Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same |
| EP1903038A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren |
| EP1903037A1 (de) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors |
| SG11202108288YA (en) * | 2019-02-01 | 2021-08-30 | Univ Leland Stanford Junior | Enpp1 inhibitors and methods of modulating immune response |
| WO2020190912A1 (en) | 2019-03-19 | 2020-09-24 | Stingray Therapeutics, Inc. | Quinoline and quinazoline compounds and methods of use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1156973A (en) * | 1965-07-06 | 1969-07-02 | Quinazoline Derivatives | |
| US3517005A (en) * | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3637701A (en) * | 1969-03-03 | 1972-01-25 | Sandoz Ag | Certain nitrate derivatives of 4-aminoquinazolines |
| DE2121031A1 (en) * | 1971-04-29 | 1972-11-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Base-substd quinazolines - thrombocyte aggregation inhibitors |
| BE793371A (fr) * | 1971-12-27 | 1973-06-27 | Sandoz Sa | Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces |
| US3819628A (en) * | 1972-07-31 | 1974-06-25 | Sandoz Ag | 2-phenyl-4-substituted amino-quinazolines and nitrates thereof |
| US3838127A (en) * | 1972-10-19 | 1974-09-24 | Sandoz Ag | 4-(4-(hydroxyalkyl)-1-piperazino)-quinazoline benzoates |
| GB1417029A (en) * | 1973-03-07 | 1975-12-10 | Pfizer Ltd | Quinazoline-derived amines |
-
1975
- 1975-01-06 GB GB41675*[A patent/GB1460389A/en not_active Expired
- 1975-07-02 IL IL47625A patent/IL47625A/xx unknown
- 1975-07-08 PH PH17358A patent/PH14190A/en unknown
- 1975-07-10 DE DE2530894A patent/DE2530894C2/de not_active Expired
- 1975-07-15 CA CA231,570A patent/CA1060445A/en not_active Expired
- 1975-07-15 SE SE7508101A patent/SE420921B/xx unknown
- 1975-07-17 BG BG030568A patent/BG27086A3/bg unknown
- 1975-07-17 BG BG035524A patent/BG27744A3/bg unknown
- 1975-07-19 RO RO7582903A patent/RO69296A/ro unknown
- 1975-07-19 RO RO7589559A patent/RO71841A/ro unknown
- 1975-07-19 RO RO7589560A patent/RO71840A/ro unknown
- 1975-07-21 DD DD187385A patent/DD119046A5/xx unknown
- 1975-07-21 JP JP8911975A patent/JPS5527062B2/ja not_active Expired
- 1975-07-21 YU YU1842/75A patent/YU37155B/xx unknown
- 1975-07-21 AR AR259676A patent/AR216046A1/es active
- 1975-07-22 FI FI752104A patent/FI66182C/fi not_active IP Right Cessation
- 1975-07-24 DK DK337175AA patent/DK138800B/da not_active IP Right Cessation
- 1975-07-24 CH CH711378A patent/CH611616A5/xx not_active IP Right Cessation
- 1975-07-24 CH CH759692A patent/CH608803A5/xx not_active IP Right Cessation
- 1975-07-24 FR FR7523218A patent/FR2279406A1/fr active Granted
- 1975-07-24 NL NL7508824.A patent/NL159982C/xx not_active IP Right Cessation
- 1975-07-24 US US05/598,723 patent/US4001422A/en not_active Expired - Lifetime
- 1975-07-24 IE IE1658/75A patent/IE41838B1/en unknown
- 1975-07-25 LU LU73072A patent/LU73072A1/xx unknown
-
1976
- 1976-01-01 AR AR263450A patent/AR207895A1/es active
- 1976-05-31 AR AR263449A patent/AR214050A1/es active
- 1976-05-31 AR AR263447A patent/AR214049A1/es active
- 1976-05-31 AR AR263451A patent/AR212447A1/es active
- 1976-05-31 AR AR263448A patent/AR213407A1/es active
-
1977
- 1977-03-01 AR AR266723A patent/AR215882A1/es active
-
1979
- 1979-08-30 HK HK618/79A patent/HK61879A/xx unknown
- 1979-09-05 KE KE2988A patent/KE2988A/xx unknown
-
1980
- 1980-12-31 MY MY1980108A patent/MY8000108A/xx unknown
-
1981
- 1981-05-14 YU YU01241/81A patent/YU124181A/xx unknown
- 1981-05-14 YU YU01242/81A patent/YU124281A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE420921B (sv) | Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan | |
| SE434395B (sv) | Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan | |
| SE424637B (sv) | Analogiforfarande for framstellning av pyridylguanidiner med terapeutisk verkan | |
| SE428562B (sv) | Forfarande for framstellning av purinderivat | |
| SE415761B (sv) | Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan | |
| SE420727B (sv) | Analogiforfarande for framstellning av bispidin- och bispidonderivat | |
| SE412066B (sv) | Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat | |
| SE409452B (sv) | Forfarande for framstellning av stilbenderivat | |
| SE7506237L (sv) | Forfarande for framstellning av dekahydroisokinolinderivat | |
| SE423390B (sv) | Foerfarande foer framstaellning av eburnameninderivat | |
| SE440907B (sv) | Forfarande for framstellning av imidazolderivat med farmaceutisk verkan | |
| SE411671B (sv) | Forfarande for framstellning av tripeptidderivat med terapeutisk verkan | |
| SE425739B (sv) | Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat | |
| SE7514308L (sv) | Forfarande for framstellning av tyrosinderivat med terapeutisk verkan | |
| SE7512292L (sv) | Forfarande for framstellning av naftalenforeningar med terapeutisk verkan | |
| SE422210B (sv) | Analogiforfarande for framstellning av substituerade indoler | |
| SE415658B (sv) | Analogiforfarande for framstellning av linnolinderivat | |
| SE7513739L (sv) | Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat | |
| SE425784B (sv) | Analogiforfarande for framstellning av eburnameninderivat | |
| SE425389B (sv) | Analogiforfarande for framstellning av vissa angivna oximetrar med antidepressiv verkan | |
| SE404364B (sv) | Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat | |
| NO149775C (no) | Analogifremgangsmaate for fremstilling av fenyl-pyridylamin-derivater med antidepressiv virkning | |
| SE7506196L (sv) | Forfarande for framstellning av amidin-hydrazon-derivat | |
| SE7608538L (sv) | Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan | |
| SE414028B (sv) | Forfarande for framstellning av terapeutisk verksamma fentiazinderivat |